Haemato AG (HAEK) — Cash Flow Reinvestment Rate

Latest as of December 2022: 0.17x

Haemato AG (HAEK) has a Cash Flow Reinvestment Rate of 0.17x as of December 2022, reinvesting €3.30 Million (capex €1.09 Million plus investments €-2.21 Million) from operating cash flow of €19.73 Million. Check earnings quality score of Haemato AG to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.17x
(Capex + Investments) / Operating CF

Total Reinvested

€3.30 Million
Capex + Investments

Operating Cash Flow

€19.73 Million
EUR

Capital Expenditures

€1.09 Million
EUR

Haemato AG Cash Flow Reinvestment Rate (2021–2022)

Historical reinvestment intensity for Haemato AG across 2 annual periods. Explore how well can Haemato AG service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Haemato AG (2021–2022)

Year-by-year capital reinvestment analysis for Haemato AG. For live market cap and broader valuation context, see Haemato AG stock valuation.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2022 0.17x €3.30 Million €19.73 Million €1.09 Million ▲ +523.3%
2021 0.03x €376.80K €14.05 Million €326.75K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow